Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective concentration and volume of ropivacaine for ultrasound-guided sacral canal block in elderly patients by gender
ChiCTR2200064111Phase 4Completed
- Sponsor
- Chongqing Traditional Chinese Medicine Hospital
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in postoperative pain and procedural pain (4 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoints: EC50 of ropivacaine for effective analgesia and EV50 of ropivacaine for effective analgesia. Started Sep 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painprocedural pain
Beyond the preview
Go deeper on ChiCTR2200064111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064111.